Agreement between RUSNANO and Domain Associates

06 March 2012

Rusnano, US fund to invest $760 mln in pharma venture

Megan Davies, Reuters

Russian state technology firm Rusnano is teaming up with a U.S. venture fund to invest around $760 million in a number of U.S. healthcare and pharmaceuticals firms, establish a manufacturing facility in Russia and bring new drugs to the Russian market.

06 March 2012

Domain partners with RusNano on $760M biotech investment plan

John Carroll, Fierce Biotech

The Russians are back. After capturing the attention of the nanobio crowd with a few hefty investments in the U.S., RusNano is now partnering with Domain Associates on a $760 million initiative that will invest in about 20 life sciences companies and construct a pharma manufacturing center in Russia to produce next-gen therapies.

06 March 2012

Rusnano Teams Up With U.S. Fund Domain to Invest in Life Science

Jason Corcoran, BLOOMBERG

Russian Nanotechnologies Corp. plans to work with Domain Associates, a U.S. venture fund, to invest $760 million in U.S. life science companies and build facilities in Russia.